ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "remission and rheumatoid arthritis (RA)"

  • Abstract Number: 2500 • 2016 ACR/ARHP Annual Meeting

    Prevalence of Sustained Remission in Patients with Rheumatoid Arthritis in Sweden. Impact of Criteria Sets and Early Treatment, a Nationwide Register Study in Sweden

    Jon T. Einarsson1, Minna Willim1, Sofia Ernestam2,3, Tore Saxne1, Pierre Geborek1 and Meliha C. Kapetanovic1, 1Lund University, Skane University Hospital, Department of Rheumatology, Lund, Sweden, Lund, Sweden, 2Clinical Epidemiology unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 3Centre of Rheumatology, Stockholm County Council, Stockholm, Sweden, Stockholm, Sweden

    Background/Purpose: The Swedish Society for Rheumatology guidelines recommend remission as treatment goal for patients with rheumatoid arthritis (RA). The Swedish quality registry (SRQ) is a…
  • Abstract Number: 2513 • 2016 ACR/ARHP Annual Meeting

    Maintained Remission in Rheumatoid Arthritis over 7 Years in «Real Life Conditions» : A Monocentric Observational Study

    Justine Vix1, Elodie Loppin1 and Elisabeth Solau-Gervais2, 1Rheumatology, University Hospital Poitiers, Poitiers, France, 2rheumatology, University Hospital Poitiers, Poitiers, France

    Background/Purpose: Remission constitutes the best achievable state in patients with rheumatoid arthritis (RA). And if remission is a goal, it need to be maintained. The…
  • Abstract Number: 2524 • 2016 ACR/ARHP Annual Meeting

    Achievement of Imaging Remission Among Patients with Rheumatoid Arthritis in Clinical Remission and Their Characteristics

    Ji-Young Choi1, Ran Song2, Seung-Jae Hong1, Hyung-In Yang2, Sang-Hoon Lee2 and Yeon-Ah Lee1, 1Rheumatology, Kyung Hee University Hospital, Seoul, South Korea, 2Rheumatology, Kyung Hee University Hospital at Gang dong, Seoul, South Korea

    Background/Purpose: Therapeutic goal of rheumatoid arthritis (RA) is to achieve disease remission. However, several remission criteria have not always equated to the complete absence of…
  • Abstract Number: 2534 • 2016 ACR/ARHP Annual Meeting

    Radiographic Remission in Patients with Seropositive RA at Ten Years after Diagnosis, Treated in a Real Life Setting

    Tuulikki Sokka1, Juha Asikainen1, Tuomas Rannio1,2 and Pekka Hannonen1, 1Jyvaskyla Central Hospital, Jyväskylä, Finland, 2Rheumatology, Jyvaskyla Central Hospital, Jyvaskyla, Finland

    Background/Purpose: Radiographs of hands and feet represent an objective outcome measure of rheumatoid arthritis (RA). Joint damage is a result of cumulative disease activity over…
  • Abstract Number: 518 • 2016 ACR/ARHP Annual Meeting

    Contribution of Patient Global Assessment on Loss and Gain of Disease Remission in Patients with Established Rheumatoid Arthritis in Clinical Practice

    George A. Karpouzas1, Elizabeth Hernandez2, Chelsie Cost2 and Sarah Ormseth2, 1Harbor UCLA Medical Center, Torrance, CA, 2Rheumatology, Harbor-UCLA Medical Center, Torrance, CA

    Background/Purpose:  Patient global assessment (PGA) is part of the remission definitions in Rheumatoid arthritis (RA). We explored the proportion of patients who fail to achieve…
  • Abstract Number: 2587 • 2016 ACR/ARHP Annual Meeting

    The Serum Level of Reactive Oxygen Metabolities (ROM) at 12 Weeks during Treatment with Biologic Agents for Rheumatoid Arthritis Is a Predictor for the 52-Week Remission

    Arata Nakajima1, Keiichiro Yamamoto2 and Koichi Nakagawa3, 1Orthopaedics, Toho University Sakura Medical Center, Sakura, Japan, 2Orthopedics, Toho University Sakura Medical Center, Sakura, Japan, 3Toho University Sakura Medical Center, Sakura, Japan

    Background/Purpose: Oxidative stress induced by reactive oxygen species is thought to be an important mechanism that underlies joint destruction and synovial proliferation. We have shown…
  • Abstract Number: 534 • 2016 ACR/ARHP Annual Meeting

    Discordance Between Physician-Stated Remission and 28-Joint Disease Activity Score (DAS28)-Defined Remission in Rheumatoid Arthritis Patients

    Nan Li1, Stuart Blackburn2, Emma Sullivan2, Danuta Kielar1 and Steve Peterson1, 1Janssen Research & Development, LLC, Spring House, PA, 2Adelphi Real World, Manchester, United Kingdom

    Background/Purpose:  Data were drawn from the 2014 Adelphi RA Disease Specific Programme in 5 European countries (France, Germany, Italy, Spain, UK). Rheumatologists provided details about…
  • Abstract Number: 2621 • 2016 ACR/ARHP Annual Meeting

    Incremental Benefit of Radiographic Inhibition on Long-Term Outcomes in Patients with Rheumatoid Arthritis

    Edward C. Keystone1, Keith A. Betts2, Casey A. Schlacher3, Yan Song2, Arijit Ganguli3 and Jenny Griffith3, 1University of Toronto, Toronto, ON, Canada, 2Analysis Group, Inc., Boston, MA, 3AbbVie Inc., North Chicago, IL

    Background/Purpose:  For the treatment of rheumatoid arthritis (RA) a therapeutic window of opportunity exists– patients treated early have favorable outcomes compared with patients treated after…
  • Abstract Number: 545 • 2016 ACR/ARHP Annual Meeting

    Utility of Power Doppler Ultrasound-Detected Synovitis for the Prediction of Short Term Flare in Rheumatoid Arthritis Patients in Clinical Remission

    Facundo Vergara1, Santiago Ruta1, Johana Zacariaz1, Josefina Marin1, Javier Rosa1, Ricardo Garcia-Monaco2 and Enrique R. Soriano1, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 2Radiology and Imagenology Department, Hospital italiano de Buenos Aires, Buenos Aires, Argentina

    Background/Purpose:  Ultrasound has been shown to detect subclinical synovitis in patients who are in clinical remission, in rheumatoid arthritis (RA). The value of power Doppler…
  • Abstract Number: 2647 • 2016 ACR/ARHP Annual Meeting

    Drug Trough Serum Levels Rather Than Antidrug Antibodies Explain Disease Flares in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with TNF Inhibitors in Clinical Remission/Low Disease Activity: A One Year Prospective, Multicenter Study (INMUNOREMAR)

    Raimon Sanmarti1, Jose Inciarte-Mundo1, Paula Estrada2, Maria García Manrique3, Javier Narváez4, Antonio Gomez-Centeno3, Jesús Rodríguez-Moreno4, Mariona Pascal5 and Jordi Yagüe5, 1Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain, 2Rheumatology Department, Hospital Moisès Broggi-Hospital General de L'Hospitalet - Consorci Sanitari Integral, Sant Joan Despí, Spain, 3Rheumatology Department, Hospital Parc Taulí, Sabadell, Spain, 4Rheumatology Department, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Spain, 5Immunology Department, Hospital Clinic de Barcelona, Barcelona, Spain

    Background/Purpose:  To determine predictive factors of disease flares, including drug trough serum levels and anti-drug antibodies (Ab) in patients with rheumatoid arthritis (RA) or polyarticular…
  • Abstract Number: 555 • 2016 ACR/ARHP Annual Meeting

    HAQ Score Is an Independent Predictor of Sustained Remission in Patients with Rheumatoid Arthritis

    Ji-Eun Kim1, Kyung-Eun Lee2, Ji-Hyoun Kang2, Yi-Rang Yim1, Jeong-Won Lee1, Lihui Wen1, Dong-Jin Park2, Tae-Jong Kim3, Yong-Wook Park2 and Shin-Seok Lee3, 1Chonnam National University Medical School and Hospital, Gwangju, South Korea, 2Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 3Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, The Republic of

    Background/Purpose:  We compared remission rates, according to different definitions of remission in rheumatoid arthritis (RA) and investigated the potential predictors of sustained remission at the…
  • Abstract Number: 3085 • 2016 ACR/ARHP Annual Meeting

    Do Depression and Anxiety Reduce the Chance of Remission in Rheumatoid Arthritis and Psoriatic Arthritis?

    Brigitte Michelsen1,2, Karen M Fagerli1, Elisabeth Lie1, Hilde Berner Hammer3, Glenn Haugeberg4,5, Eirik K Kristianslund1 and Tore K. Kvien1, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept. of Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Dept. of Rheumatology, Martina Hansens Hospital, Bærum, Norway, 5Dept. of Rheumatology, The Norwegian University of Science and Technology, Trondheim, Norway

    Background/Purpose: Depression and anxiety are reported to predict poorer treatment outcomes in rheumatoid arthritis (RA).1 Whether this can be confirmed in larger, prospective studies as…
  • Abstract Number: 2619 • 2015 ACR/ARHP Annual Meeting

    Clinical Usefulness of Periodic Detection of Serum 14-3-3η for Predicting Efficacy of Tocilizumab in RA

    Akira Sagawa1, Takuya Isayama2, Makoto Kaneda3, Yuan Gui4, Anthony Marotta5 and Jiro Arai2, 1Sagawa Akira Rheumatology Clinic, Sapporo, Japan, 2Medical and Biological Laboratories Co., Ltd., Ina, Japan, 3MBL Europe, Diegem, Belgium, 4Augurex Life Sciences Corp., North Vancouver, BC, Canada, 51423 Dempsey Road, Augurex Life Sciences Corp., North Vancouver, BC, Canada

    Background/Purpose: Serum 14-3-3η is a diagnostic marker for RA. Recent in vitro evidence indicates that it may play a casual role in the pathogenesis of…
  • Abstract Number: 2608 • 2015 ACR/ARHP Annual Meeting

    The “Rheumatoid Arthritis Impact of Disease”� Score Correlates with Other Patient Reported Outcomes and with Disease Activity Scores in Patients with RA and Its Patient Acceptable Symptom State Is More Stringent Than DAS28-Remission

    Ricardo J.O. Ferreira1,2, Cátia Duarte1,3, Sylvie Batista3, Catarina Medeiros3, J.P. Sousa3, Gisela Eugénio1, Carlos Costa1, Pedro Carvalho1, Joana F. Ferreira1, Margarida Coutinho1,4, Maria J. Salvador1,4, Laure Gossec5 and J.A.P. da Silva3,6, 1Rheumatology, Centro Hospitalar e Universitário de Coimbra - Hospitais da Universidade de Coimbra, EPE, Coimbra, Portugal, 2Health Sciences Research Unit: Nursing (UICISA: E), Coimbra, Portugal, 3Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal, 4Clínica Universitária de Reumatologia, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal, 5Rheumatology, Pitié Salpetriere Hospital, Paris, France, 6Centro Hospitalar e Universitário de Coimbra - Hospitais da Universidade de Coimbra, EPE, Coimbra, Portugal

    Background/Purpose: The "Rheumatoid Arthritis Impact of Disease" (RAID) score is a Patient Reported Outcome (PRO) that comprises seven domains of disease[1], that may reflect the…
  • Abstract Number: 2584 • 2015 ACR/ARHP Annual Meeting

    Prediction of Disease Relapses By Multi-Biomarker Disease Test Activity in Rheumatoid Arthritis Patients Tapering DMARD Treatment

    Juergen Rech1, Axel J. Hueber2, Matthias Englbrecht2, Stephanie Finzel3, Judith Haschka4,5, Bernhard Manger2, Arnd Kleyer3, Michaela Reiser3, Hans-Peter Tony6, Stefan Kleinert7, Martin Feuchtenberger8, Martin Fleck9, Karin Manger10, Wolfgang Ochs11, Matthias Schmitt-Haendle12, Joerg Wendler13, Florian Schuch13, Monika Ronneberger13, Hanns-Martin Lorenz14, Hubert Nüßlein15, Rieke Alten16, Jayme Fogagnolo Cobra17, Joerg C. Henes18, Klaus Krüger19 and Georg A. Schett20, 1medical clinic 3, University of Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3, Rheumatology & Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 3Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 4Medical Department 3, Rheumatology & Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 5Medical Department II, Medical University of Vienna, St. Vincent Hospital Vienna,, Vienna, Austria, 6University Hospital Würzburg, Würzburg, Germany, 7Rheumatologische Schwerpunktpraxis Erlangen, Erlangen, Germany, 8Rheumatologie/Klinische Immunologie, Kreiskliniken Altötting-Burghausen, Burghausen, Germany, 9Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany, 10Rheumatology Practice Bamberg, Bamberg, Germany, 11Rheumatologist in Private Practice, Bayreuth, Germany, 12Rheumatology Practice, Bayreuth, Germany, 13Schwerpunktpraxis Rheumatologie, Erlangen, Germany, 14University Hospital Heidelberg, Heidelberg, Germany, 15University Erlangen, Nürnberg, Germany, 16Internal Medicine, Rheumatology & Clinical Immunology, Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany, 17Instituto de Reumatologia de Sao Paolo, Sao Paolo, Brazil, 18Department of Internal Medicine II, Rheumatology Division, University Hospital Tuebingen, Tuebingen, Germany, 19Praxiszentrum St. Bonifatius, München, Germany, 20University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: To analyze the role of multi-biomarker disease activity (MBDA) in predicting disease relapses in rheumatoid arthritis (RA) patients in sustained remission, tapering disease modifying…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies